PENNISI, MARTINA
PENNISI, MARTINA
Dipartimento di Oncologia ed Emato-Oncologia
Axicabtagene ciloleucel treatment is more effective in primary mediastinal large B-cell lymphomas than in diffuse large B-cell lymphomas: the Italian CART-SIE study
2024 A. Chiappella, B. Casadei, P. Chiusolo, A. Di Rocco, S. Ljevar, M. Magni, P. Angelillo, A.M. Barbui, I. Cutini, A. Dodero, F. Bonifazi, M.C. Tisi, S. Bramanti, M. Musso, M. Farina, M. Martino, M. Novo, G. Grillo, F. Patriarca, G. Zacchi, M. Krampera, M. Pennisi, E. Galli, M. Martelli, A.J.M. Ferreri, S. Ferrari, R. Saccardi, A. Bermema, A. Guidetti, R. Miceli, P.L. Zinzani, P. Corradini
Nonrestrictive diet does not increase infections during post-HSCT neutropenia: data from a multicenter randomized trial
2023 F. Stella, V. Marasco, G.V. Levati, A. Guidetti, A. De Filippo, M. Pennisi, C. Vismara, R. Miceli, S. Ljevar, C. Tecchio, N. Mordini, G. Gobbi, L. Saracino, P. Corradini
Phenotypic composition of commercial anti-CD19 CAR-T cells affects in vivo expansion and disease response in large B-cell lymphoma patients
2022 C. Monfrini, F. Stella, V. Aragona, M. Magni, S. Ljevar, C. Vella, E. Fardella, A. Chiappella, F. Nanetti, M. Pennisi, A. Dodero, A. Guidetti, P. Corradini, C. Carniti
Dose-Adjusted Epoch and Rituximab for the treatment of double expressor and double hit diffuse large B-cell lymphoma: impact of TP53 mutations on clinical outcome
2021 A. Dodero, A. Guidetti, F. Marino, A. Tucci, F. Barretta, A. Re, M. Balzarotti, C. Carniti, C. Monfrini, A. Chiappella, A. Cabras, F. Facchetti, M. Pennisi, D. Rahal, V. Monti, L. Devizzi, R. Miceli, F. Cocito, L. Farina, F. Ricci, G. Rossi, C. Carlo-Stella, P. Corradini
Multiple sclerosis disease: A computational approach for investigating its drug interactions
2020 S. Pernice, M. Beccuti, G. Romano, M. Pennisi, A. Maglione, S. Cutrupi, F. Pappalardo, L. Capra, G. Franceschinis, M. De Pierro, G. Balbo, F. Cordero, R. Calogero
Dose-adjusted EPOCH plus rituximab improves the clinical outcome of young patients affected by double expressor diffuse large B-cell lymphoma
2019 A. Dodero, A. Guidetti, A. Tucci, F. Barretta, M. Novo, L. Devizzi, A. Re, A. Passi, A. Pellegrinelli, G. Pruneri, R. Miceli, A. Testi, M. Pennisi, M.C. Di Chio, P. Matteucci, C. Carniti, F. Facchetti, G. Rossi, P. Corradini
Ocular disorders in multiple myeloma patients: cross-sectional study of prevalence and association with treatment
2018 M. Pennisi, L. Berchicci, E. Miserocchi, A. Mussetti, V. Cacioppo, A. David, A. Scialdone, I. Lorusso, G. Modorati, P. Corradini, V. Montefusco
Real-life feasibility of salvage allogeneic transplantation in peripheral T-cell lymphomas
2018 A. Mussetti, N. Martinetti, N. Cieri, M. Pennisi, A. Dodero, P. Corradini
Italian expert panel consensus statement on the optimal use of PD-1 blockade therapy in classical Hodgkin lymphoma
2018 P.L. Zinzani, A. Santoro, A. Chiti, S. Lastoria, A. Pinto, L. Rigacci, G. Barosi, M. Pennisi, P. Corradini
Bone Marrow Fibrosis and Early Hematological Response as Predictors of Poor Outcome in Azacitidine Treated High Risk-Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia
2018 G. Reda, M. Riva, B. Fattizzo, R. Cassin, D. Giannarelli, M. Pennisi, A. Freyrie, R. Cairoli, A. Molteni, A. Cortelezzi
CD3+ graft cell count influence on chronic GVHD in haploidentical allogeneic transplantation using post-transplant cyclophosphamide
2018 A. Mussetti, C. de Philippis, C. Carniti, M. Bastos-Oreiro, J. Gayoso, N. Cieri, M. Pennisi, F. Ciceri, R. Greco, J. Peccatori, F. Patriarca, J. Mariotti, L. Castagna, P. Corradini
Allogeneic stem cell transplantation and subsequent treatments as a comprehensive strategy for long-term survival of multiple myeloma patients
2017 M. V, M. A, R. F, F. Maura, M. Pennisi, C. DE PHILIPPIS, M. Capecchi, P. Corradini
Pregnancy in β-thalassemia intermedia at two tertiary care centers in Lebanon and Italy : a follow-up report on fetal and maternal outcomes
2017 J.E. Roumi, H.M. Moukhadder, G. Graziadei, M. Pennisi, M.D. Cappellini, A.T. Taher
Impact of Bone Marrow Fibrosis and Early Response on Outcome after Azacitidine Therapy in 94 Patients with Myelodisplastic Syndromes, Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia
2016 G. Reda, M. Riva, R. Cassin, B. Fattizzo, M. Pennisi, D. Giannarelli, A. Molteni, A. Freyrie, R. Cairoli, A. Cortelezzi
High-dose chemotherapy followed by autologous transplantation may overcome the poor prognosis of diffuse large B-cell lymphoma patients with MYC/BCL2 co-expression
2016 F. Maura, A. Guidetti, A. Pellegrinelli, A. Dodero, M. Pennisi, C. Caprioli, A. Testi, L. Farina, N. Bolli, L.F. Devizzi, A.D. Cabras, P. Corradini
GATA-3 Expression in Peripheral T-Cell Lymphomas (PTCL): Identification of a Cut-Off and Prognostic Value in PTCL-NOS Versus Others Hystotypes
2015 A. Dodero, F. Maura, A. Pellegrinelli, A.D. Cabras, A. Chiappella, D. Novero, F. Vittone, F. Zaja, S. Pizzolitto, C. Carniti, A. Cavane', M. Pennisi, U. Vitolo, N. Bolli, P. Corradini